Evidence map›Paper›PMID 24494198›Full record

ArticleRedox biology2014

Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide.

Miriam M Cortese-Krott, Bernadette O Fernandez, José L T Santos, Evanthia Mergia, Marian Grman, Péter Nagy, Malte Kelm, Anthony Butler, Martin Feelisch

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 149 citations in OpenAlex.

  1. Intracellular Crosstalk of the Gasotransmitter Trio (NO, CO, HInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Signaling Paradigms of HAntioxidants (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Article
  12. The Triple Crown: NO, CO, and HPharmacology & therapeutics · 2023
    Review
  13. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  14. Review
  15. Human Cystathionine γ-Lyase Is Inhibited byAntioxidants (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Cardiovascular "Patterns" of HBiomolecules · 2021
    Article
  18. Review
  19. RSC advances · 2020
    Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Miriam M Cortese-KrottCardiovascular Research Laboratory, Department of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
Bernadette O FernandezClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK.
José L T SantosClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK.
Evanthia MergiaInstitute for Pharmacology and Toxicology, Ruhr-University Bochum, Bochum, Germany.
Marian GrmanInstitute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Péter NagyDepartment of Molecular Immunology and Toxicology, National Institute of Oncology, Ráth György utca 7-9, Budapest, Hungary.
Malte KelmCardiovascular Research Laboratory, Department of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
Anthony ButlerMedical School, University of St-Andrews, St-Andrews, Fife, Scotland.
Martin FeelischClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK.
Heinrich Heine University Düsseldorf · DEUniversity of Southampton · GBNational Institute of Oncology · HURuhr University Bochum · DESlovak Academy of Sciences · SKSouthampton General Hospital · GBUniversity of St Andrews · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfide salts are known to promote the release of nitric oxide (NO) from S-nitrosothiols and potentiate their vasorelaxant activity, but much of the cross-talk between hydrogen sulfide and NO is believed to occur via functional interactions of cell regulatory elements such as phosphodiesterases. Using RFL-6 cells as an NO reporter system we sought to investigate whether sulfide can also modulate nitrosothiol-mediated soluble guanylyl cyclase (sGC) activation following direct chemical interaction. We find a U-shaped dose response relationship where low sulfide concentrations attenuate sGC stimulation by S-nitrosopenicillamine (SNAP) and cyclic GMP levels are restored at equimolar ratios. Similar results are observed when intracellular sulfide levels are raised by pre-incubation with the sulfide donor, GYY4137. The outcome of direct sulfide/nitrosothiol interactions also critically depends on molar reactant ratios and is accompanied by oxygen consumption. With sulfide in excess, a 'yellow compound' accumulates that is indistinguishable from the product of solid-phase transnitrosation of either hydrosulfide or hydrodisulfide and assigned to be nitrosopersulfide (perthionitrite, SSNO(-); λ max 412 nm in aqueous buffers, pH 7.4; 448 nm in DMF). Time-resolved chemiluminescence and UV-visible spectroscopy analyses suggest that its generation is preceded by formation of the short-lived NO-donor, thionitrite (SNO(-)). In contrast to the latter, SSNO(-) is rather stable at physiological pH and generates both NO and polysulfides on decomposition, resulting in sustained potentiation of SNAP-induced sGC stimulation. Thus, sulfide reacts with nitrosothiols to form multiple bioactive products; SSNO(-) rather than SNO(-) may account for some of the longer-lived effects of nitrosothiols and contribute to sulfide and NO signaling.

Indexed as

AnimalsCell LineCyclic GMPGuanylate CyclaseMorpholinesNitric OxideNitric Oxide DonorsNitroso CompoundsOrganothiophosphorus CompoundsOxygen ConsumptionRatsReceptors, Cytoplasmic and NuclearS-NitrosothiolsSoluble Guanylyl CyclaseSulfidesCyclic GMPGuanylate CyclaseGYY 4137MorpholinesNitric OxideNitric Oxide DonorsNitroso CompoundsOrganothiophosphorus CompoundspersulfidesReceptors, Cytoplasmic and NuclearS-nitrosopenicillamineS-NitrosothiolsSoluble Guanylyl CyclaseSulfidescGMPCysNO, S-nitrosocysteineDMF, dimetylformamideDMSO, dimethylsulfoxideGSNO, S-nitrosoglutathioneHSNOHydrogen sulfideIPN, isopentyl nitriteNitric oxideNitroxylNO, nitric oxideNO+, nitrosoniumPolysulfidesRFL-6, rat fibroblastoid-like cell linesGC, soluble guanylyl cyclaseSNAP, S-nitrosopenicillamineSNO−, thionitriteSSNO−, nitrosopersulfide, perthionitrite, PDE, phopsphodiesterase

Identifiers

PMID24494198
PMCPMC3909780
OpenAlexW2037151440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.